These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18311155)

  • 1. Clinical pharmacological issues in the development of acute stroke therapies.
    Ford GA
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S112-9. PubMed ID: 18311155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.
    Green AR
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S325-38. PubMed ID: 18059324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
    Savitz SI
    Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
    Sutherland BA; Minnerup J; Balami JS; Arba F; Buchan AM; Kleinschnitz C
    Int J Stroke; 2012 Jul; 7(5):407-18. PubMed ID: 22394615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2007 Feinberg lecture: a new road map for neuroprotection.
    Donnan GA
    Stroke; 2008 Jan; 39(1):242. PubMed ID: 18048866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
    Green AR; Ashwood T
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
    Schmidt A; Minnerup J; Kleinschnitz C
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NXY-059: review of neuroprotective potential for acute stroke.
    Fong JJ; Rhoney DH
    Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection for ischemic stroke: past, present and future.
    Ginsberg MD
    Neuropharmacology; 2008 Sep; 55(3):363-89. PubMed ID: 18308347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection in cerebral ischemia: emphasis on the SAINT trial.
    Chacon MR; Jensen MB; Sattin JA; Zivin JA
    Curr Cardiol Rep; 2008 Feb; 10(1):37-42. PubMed ID: 18416999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental neuroprotection in ischemic stroke: a concise review.
    Rajah GB; Ding Y
    Neurosurg Focus; 2017 Apr; 42(4):E2. PubMed ID: 28366067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection for stroke: current status and future perspectives.
    Minnerup J; Sutherland BA; Buchan AM; Kleinschnitz C
    Int J Mol Sci; 2012; 13(9):11753-11772. PubMed ID: 23109881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quest for Quality in Translational Stroke Research-A New Dawn for Neuroprotection?
    Haupt M; Gerner ST; Bähr M; Doeppner TR
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time is Penumbra: imaging, selection and outcome. The Johann jacob wepfer award 2014.
    Davis S; Donnan GA
    Cerebrovasc Dis; 2014; 38(1):59-72. PubMed ID: 25227260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of neuroprotective agents in the treatment of acute ischemic stroke.
    Lutsep HL; Clark WM
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):13-8. PubMed ID: 11898495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.